Vidar Gordon Flote

  • Consultant
 

Publications 2023

Mikalsen SG, Skjøtskift T, Flote VG, Hämäläinen NP, Heydari M, Rydén-Eilertsen K (2023)
Extensive clinical testing of Deep Learning Segmentation models for thorax and breast cancer radiotherapy planning
Acta Oncol, 62 (10), 1184-1193
DOI 10.1080/0284186X.2023.2270152, PubMed 37883678

Riis ML, Augestad L, Flote VG, Tangerud A, Frich L (2023)
Simultaneous cutaneous melanoma and ipsilateral breast cancer with metastasis to the same axilla. A case report with a focus on a multidisciplinary approach
Int J Surg Case Rep, 114, 109119
DOI 10.1016/j.ijscr.2023.109119, PubMed 38061088

Publications 2022

Brunvoll SH, Flote VG, Halset EH, Bertheussen GF, Skjerven H, Lømo J, Thune I, Hjartåker A (2022)
Normal and unusual days for dietary intake during the 12 months after a breast cancer diagnosis in women
Eur J Nutr, 61 (8), 3873-3885
DOI 10.1007/s00394-022-02925-9, PubMed 35750881

Stalsberg R, Bertheussen GF, Børset H, Thomsen SN, Husøy A, Flote VG, Thune I, Lundgren S (2022)
Do Breast Cancer Patients Manage to Participate in an Outdoor, Tailored, Physical Activity Program during Adjuvant Breast Cancer Treatment, Independent of Health and Socio-Demographic Characteristics?
J Clin Med, 11 (3)
DOI 10.3390/jcm11030843, PubMed 35160292

Svestad JG, Heydari M, Mikalsen SG, Flote VG, Nordby F, Hellebust TP (2022)
Surface-guided positioning eliminates the need for skin markers in radiotherapy of right sided breast cancer: A single center randomized crossover trial
Radiother Oncol, 177, 46-52
DOI 10.1016/j.radonc.2022.10.017, PubMed 36309152

Publications 2021

Bøhn SK, Thune I, Flote VG, Frydenberg H, Bertheussen GF, Husøy A, Fjeldheim F, Brunvoll SH, Hjartåker A, Mowinckel MC, Sandset PM, Iversen PO (2021)
Effects of a 1-Year Physical Activity Intervention on Markers of Hemostasis among Breast Cancer Survivors: A Randomized Controlled Trial
TH Open, 5 (1), e14-e23
DOI 10.1055/s-0040-1721782, PubMed 33564742

Publications 2020

Brunvoll SH, Thune I, Bertheussen GF, Fjeldheim F, Flote VG, Frydenberg H, Lundgren S, Skjerven H, Lømo J, Fagerland MW, McTiernan A, Schlichting E, Hjartåker A (2020)
Dietary changes in early-stage breast cancer patients from pre-surgery and over the 12 months post-surgery
Br J Nutr, 125 (2), 172-182
DOI 10.1017/S0007114520002627, PubMed 32811572

Lofterød T, Frydenberg H, Flote V, Eggen AE, McTiernan A, Mortensen ES, Akslen LA, Reitan JB, Wilsgaard T, Thune I (2020)
Exploring the effects of lifestyle on breast cancer risk, age at diagnosis, and survival: the EBBA-Life study
Breast Cancer Res Treat, 182 (1), 215-227
DOI 10.1007/s10549-020-05679-2, PubMed 32436147

Publications 2018

Brunvoll SH, Thune I, Frydenberg H, Flote VG, Bertheussen GF, Schlichting E, Bjerve KS, Hjartåker A (2018)
Validation of repeated self-reported n-3 PUFA intake using serum phospholipid fatty acids as a biomarker in breast cancer patients during treatment
Nutr J, 17 (1), 94
DOI 10.1186/s12937-018-0402-6, PubMed 30333016

Halvorsen AR, Sandhu V, Sprauten M, Flote VG, Kure EH, Brustugun OT, Helland Å (2018)
Circulating microRNAs associated with prolonged overall survival in lung cancer patients treated with nivolumab
Acta Oncol, 57 (9), 1225-1231
DOI 10.1080/0284186X.2018.1465585, PubMed 29683761

Madssen TS, Thune I, Flote VG, Lundgren S, Bertheussen GF, Frydenberg H, Wist E, Schlichting E, Schäfer H, Fjøsne HE, Vettukattil R, Lømo J, Bathen TF, Giskeødegård GF (2018)
Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment
Br J Cancer, 119 (9), 1144-1154
DOI 10.1038/s41416-018-0211-x, PubMed 30401977

Publications 2016

Fjeldheim FN, Frydenberg H, Flote VG, McTiernan A, Furberg AS, Ellison PT, Barrett ES, Wilsgaard T, Jasienska G, Ursin G, Wist EA, Thune I (2016)
Polymorphisms in the estrogen receptor alpha gene (ESR1), daily cycling estrogen and mammographic density phenotypes
BMC Cancer, 16 (1), 776
DOI 10.1186/s12885-016-2804-1, PubMed 27717337

Flote VG, Vettukattil R, Bathen TF, Egeland T, McTiernan A, Frydenberg H, Husøy A, Finstad SE, Lømo J, Garred Ø, Schlichting E, Wist EA, Thune I (2016)
Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer
Lipids Health Dis, 15, 56
DOI 10.1186/s12944-016-0225-4, PubMed 26970778

Frydenberg H, Thune I, Lofterød T, Mortensen ES, Eggen AE, Risberg T, Wist EA, Flote VG, Furberg AS, Wilsgaard T, Akslen LA, McTiernan A (2016)
Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival
Breast Cancer Res Treat, 155 (2), 345-54
DOI 10.1007/s10549-015-3671-1, PubMed 26740213

Iversen A, Frydenberg H, Furberg AS, Flote VG, Finstad SE, McTiernan A, Ursin G, Wilsgaard T, Ellison PT, Jasienska G, Thune I (2016)
Cyclic endogenous estrogen and progesterone vary by mammographic density phenotypes in premenopausal women
Eur J Cancer Prev, 25 (1), 9-18
DOI 10.1097/CEJ.0000000000000130, PubMed 25714648

Publications 2015

Flote VG, Frydenberg H, Ursin G, Iversen A, Fagerland MW, Ellison PT, Wist EA, Egeland T, Wilsgaard T, McTiernan A, Furberg AS, Thune I (2015)
High-density lipoprotein-cholesterol, daily estradiol and progesterone, and mammographic density phenotypes in premenopausal women
Cancer Prev Res (Phila), 8 (6), 535-44
DOI 10.1158/1940-6207.CAPR-14-0267, PubMed 25804612

Frydenberg H, Flote VG, Larsson IM, Barrett ES, Furberg AS, Ursin G, Wilsgaard T, Ellison PT, McTiernan A, Hjartåker A, Jasienska G, Thune I (2015)
Alcohol consumption, endogenous estrogen and mammographic density among premenopausal women
Breast Cancer Res, 17 (1), 103
DOI 10.1186/s13058-015-0620-1, PubMed 26246001

Publications 2014

Flote VG, Furberg AS, McTiernan A, Frydenberg H, Ursin G, Iversen A, Lofteroed T, Ellison PT, Wist EA, Egeland T, Wilsgaard T, Makar KW, Chang-Claude J, Thune I (2014)
Gene variations in oestrogen pathways, CYP19A1, daily 17β-estradiol and mammographic density phenotypes in premenopausal women
Breast Cancer Res, 16 (6), 499
DOI 10.1186/s13058-014-0499-2, PubMed 25522654

Frydenberg H, Flote VG, Iversen A, Finstad SE, Furberg AS, Torjesen PA, Wilsgaard T, Schlichting E, Ellison PT, Ursin G, Thune I (2014)
Insulin-like growth factor-1, growth hormone, and daily cycling estrogen are associated with mammographic density in premenopausal women
Cancer Causes Control, 25 (7), 891-903
DOI 10.1007/s10552-014-0389-z, PubMed 24801047

Publications 2012

Iversen A, Thune I, McTiernan A, Makar KW, Wilsgaard T, Ellison PT, Jasienska G, Flote V, Poole EM, Furberg AS (2012)
Genetic polymorphism CYP17 rs2486758 and metabolic risk factors predict daily salivary 17β-estradiol concentration in healthy premenopausal Norwegian women. The EBBA-I study
J Clin Endocrinol Metab, 97 (5), E852-7
DOI 10.1210/jc.2011-2577, PubMed 22419734

Publications 2011

Iversen A, Thune I, McTiernan A, Emaus A, Finstad SE, Flote V, Wilsgaard T, Lipson SF, Ellison PT, Jasienska G, Furberg AS (2011)
Ovarian hormones and reproductive risk factors for breast cancer in premenopausal women: the Norwegian EBBA-I study
Hum Reprod, 26 (6), 1519-29
DOI 10.1093/humrep/der081, PubMed 21467202

Publications 2000

Flote VG, Gilhus NE (2000)
[Patients with cluster headache in a neurological department]
Tidsskr Nor Laegeforen, 120 (29), 3510-2
PubMed 11188375

Page visits: 6917